Newswise — MAYWOOD, Ill. – (July 10, 2014) Although it is rare, tuberous sclerosis complex (TSC) can be a difficult and frightening diagnosis for parents and children. The genetic disorder causes nonmalignant tumors to form in many different organs, including the brain, eyes, kidneys and heart. If a child’s brain is affected by the disease, it can be especially debilitating since it can cause seizures, developmental delays, intellectual disability and autism.
“TSC is not easily diagnosed because the main symptoms are white spots on the skin that can’t be seen by the naked eye and abnormal growth in the heart muscle, which sometimes can be found in an ultrasound during pregnancy,” said Nikolas Mata-Machado, MD, pediatric neurologist at Loyola University Health System and assistant professor in the departments of neurology and pediatrics at Loyola University Chicago Stritch School of Medicine.
Because the disease can affect multiple organs, Mata-Machado said it’s important for parents to find a center that has a multidisciplinary team.
“It’s not just about the brain or heart; it’s about how this disease is affects many areas of a child’s body. I work with pediatric experts in many medical fields including nephrology, cardiology, pulmonology, hepatology and neuropsychology,” Mata-Machado said.
Though there is no cure for TSC, Mata-Machado is one of only a few physicians to use a new drug treatment similar to chemotherapy that causes the tumors to shrink, and offering hope to many patients who do not respond to traditional treatments.
“There are surgical options and also some patients respond well to anti-seizure medications. Unfortunately, I have some patients who do not respond to these medications, some still having up to 40 seizures a day and others are not candidates for surgery. This new treatment gives these patients and their families another chance, a hope,” said Mata-Machado.
TSC is a genetic disorder found in 1 of every 25,000 children. It is estimated that 50,000 people in the U.S. are living with the disorder and possibly more because it is difficult to diagnose. The severity of the disease varies greatly, with some patients able to live independent, healthy lives into adulthood.
“It is important for someone with TSC to be monitored by a physician throughout their life as complications can cause serious medical conditions and even death if left untreated,” said Mata-Machado. “Still, with advances in medicine and research we are able to offer patients more options for living with this disorder.”
For media inquires, please contact Evie Polsley at firstname.lastname@example.org or call (708) 216-5313 or (708) 417-5100. Follow Loyola on: Facebook:http://www.facebook.com/#!/LoyolaHealthTwitter:http://twitter.com/#!/LoyolaHealthYouTube:http://www.youtube.com/user/LoyolaHealth### Loyola University Health System, a member of Trinity Health, is a quaternary care system based in the western suburbs. It includes a 61-acre main medical center campus, the 36-acre Gottlieb Memorial Hospital campus and 22 primary and specialty care facilities in Cook, Will and DuPage counties. The medical center campus is conveniently located in Maywood, 13 miles west of the Chicago Loop and 8 miles east of Oak Brook, Ill. The heart of the medical center campus, Loyola University Hospital, is a 569-licensed-bed facility. It houses a Level 1 Trauma Center, a Burn Center and the Ronald McDonald® Children’s Hospital of Loyola University Medical Center. Also on campus are the Cardinal Bernardin Cancer Center, Loyola Outpatient Center, Center for Heart & Vascular Medicine and Loyola Oral Health Center as well as the LUC Stritch School of Medicine, the LUC Marcella Niehoff School of Nursing and the Loyola Center for Fitness. Loyola's Gottlieb campus in Melrose Park includes the 264-licensed-bed community hospital, the Professional Office Building housing 150 private practice clinics, the Adult Day Care, the Gottlieb Center for Fitness and Marjorie G. Weinberg Cancer Care Center.